Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anaptysbio (ANAB) Return on Capital Employed (2017 - 2025)

Anaptysbio (ANAB) has disclosed Return on Capital Employed for 9 consecutive years, with 0.01% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed rose 25.0% year-over-year to 0.01%, compared with a TTM value of 0.01% through Dec 2025, up 25.0%, and an annual FY2025 reading of 0.01%, up 26.0% over the prior year.
  • Return on Capital Employed was 0.01% for Q4 2025 at Anaptysbio, up from 0.09% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.01% in Q4 2025 and bottomed at 0.41% in Q1 2024.
  • Average Return on Capital Employed over 5 years is 0.21%, with a median of 0.2% recorded in 2022.
  • The sharpest move saw Return on Capital Employed decreased -18bps in 2023, then grew 25bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.11% in 2021, then tumbled by -78bps to 0.2% in 2022, then tumbled by -94bps to 0.38% in 2023, then surged by 32bps to 0.26% in 2024, then surged by 97bps to 0.01% in 2025.
  • Business Quant data shows Return on Capital Employed for ANAB at 0.01% in Q4 2025, 0.09% in Q3 2025, and 0.25% in Q1 2025.